Abstract:Antibiotic resistance has become a major threat, contributing significantly to morbidity and mortality globally. Administering non-antibiotic therapy, such as antimicrobial peptides, is one potential strategy for effective treatment of multi-drug-resistant Gram-negative bacterial infections. Bactericidal/permeability-increasing protein (BPI) derived from neutrophils has bactericidal and endotoxin-neutralizing activity. However, the protective roles and mechanisms of BPI in multi-drug-resistant bacterial infections have not been fully elucidated. In this study, a chimeric BPI23-Fcγ recombined protein comprising the functional N terminus of BPI and Fcγ was constructed and expressed by adenovirus vector 5 (Ad5). Ad5-BPI23-Fcγ or recombinant BPI23-Fcγ protein significantly improved the survival of mice with pneumonia induced by a minimal lethal dose of multi-drug-resistant Acinetobacter baumannii or Klebsiella pneumoniae by ameliorating lung pathology and reducing pro-inflammatory cytokines. Transfection with Ad5-BPI23-Fcγ significantly decreased the bacterial load and endotoxaemia, which was associated with enhanced bactericidal ability and elevated the phagocytic activity of neutrophils in vitro and in vivo. In addition, Ad5-BPI23-Fcγ transfection significantly increased the recruitment of neutrophils to lung, increased the proportion and number of neutrophils in peripheral blood, and promoted the maturation of bone marrow (BM) neutrophils after drug-resistant A. baumannii infection. BPI23-Fcγ and neutrophils synergistically enhanced bactericidal activity and decreased pro-inflammatory cytokines. These results demonstrated that the chimeric BPI23-Fcγ protein protected mice from pneumonia induced by multi-drug-resistant A. baumannii infection by direct bactericidal effects and promotion of neutrophil recruitment, phagocytosis and maturation. Chimeric BPI23-Fcγ may be a promising candidate as a non-antibiotic biological agent for multi-drug-resistant A. baumannii infection.

Expression of BPIm23-Fcγ1 Recombinant Bactericidal Protein in CHO Cell and Primary Study of Its Effect on Drug Resistance Bacteria

BPI23-Fcγ alleviates lethal multi-drug-resistant Acinetobacter baumannii infection by enhancing bactericidal activity and orchestrating neutrophil function

Expression of recombinant BC047440 protein and its effects on proliferation of HepG2 cells in vitro

Constructing Prokaryotic Vector of BC047440 Gene Expression and Purification of Its Recombinant Protein

Cloning of N-terminal functional gene fragment of murine BPI gene and studies on its intracellular bacteriocide function

Identification of N-terminal fragment of human bactericidal/permeability increasing protein displayed on the surface of yeast cells

Establishment of prokar yotic expression system of autoantigen human bactericidal/permeability-incre-asing fold-containing B1

Expression of tumor necrosis factor receptor-immunoglobulin G1 Fc fusion protein in glycoengineered Pichia pastoris

[Construction, Expression and Purification of a Mammalian Secretory Recombinant Fusion Protein Rpc].

Soluble fusion expression and characterization of bioactive human beta-defensin 26 and 27

Design and Unique Expression of a Novel Antibacterial Fusion Protein Cecropin B-Human Lysozyme to Be Toxic to Prokaryotic Host Cells

Prokaryotic Expression and Functional Verification of Antimicrobial Peptide LRGG

[Construction and Expression of Prokaryotic Vector of Single Chain Antibody Derived from a New Clone of Anti-Cd14 Antibody ZCH-7-2F9].

Expression of Hybrid Peptide EF-1 in Pichia pastoris, Its Purification, and Antimicrobial Characterization

[Expression of hemolytic phospholipase C from Pseudomonas aeruginosa in Escherichia coli].

Characterization of the broad-spectrum antibacterial activity of bacteriocin-like inhibitory substance-producing probiotics isolated from fermented foods

Expression of the hybrid antimicrobial peptide lactoferrin–lysozyme in Pichia pastoris

Recombinant expression, purification, and antimicrobial activity of a novel hybrid antimicrobial peptide LFT33

Inhibitory Potential of Bifidobacterium longum FB1-1 Cell-Free Supernatant against Carbapenem-Resistant Klebsiella pneumoniae Drug Resistance Spread

Expression, purification of ImiS and kinetic studies on hydrolysis of three types of β-lactam antibiotics catalyzed by ImiS

Design and high-level expression of a hybrid antimicrobial peptide LF15-CA8 in Escherichia coli